Myriad Genetics MYGN Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
Plus components not separately reported this period.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's total debt?
- Myriad Genetics (MYGN) reported total debt of $211.5M in Q1 2026.
- How has Myriad Genetics's total debt changed year-over-year?
- Myriad Genetics's total debt increased by 34.2% year-over-year, from $157.6M to $211.5M.
- What is the long-term trend for Myriad Genetics's total debt?
- Over 5 years (2020 to 2025), Myriad Genetics's total debt has grown at a -6.2% compound annual growth rate (CAGR), from $289M to $209.8M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.